← Leaderboards
Lixing W Reneker
Mellon Pitts Corporation (Mpc Corp)
$5,093,980
Attributed
$5,312,503
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $422.2K · FY2006–25$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,312,503 · 5
By mechanism
R01$4,453,257 · 2
R21$859,246 · 2
P41$0 · 1
Top collaborators
- Andrew J.W. Huang2 shared
Others in their field
Top investigators on “Lens”
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$171,224,107
- Michael Cohen-Wolkowiez · Duke University$34,499,656
- Rohit Varma · University Of Southern California$28,661,355
- Ales Cvekl · Yeshiva University$24,388,603
- Thomas J. Grabowski · University Of Iowa$19,645,459
- Warren A Kibbe · Duke University$19,297,527
Research focus
LensPlayCell ProliferationSignal TransductionReceptor SignalingFibroblast Growth Factor ReceptorsStructureFibroblast Growth FactorCell Differentiation ProcessCell SurvivalPathway InteractionsCell DeathApoptosisKnockout MicePhosphatidylinositolsSignal PathwayMouse ModelPreventBlindnessGenesCessation Of LifeReceptorMediatingMitochondria
Grant awards (21)
Targeting Sex Hormone Receptors for Treatment of Meibomian Gland Dysfunction$422,199
R21 · FY2025 · EY · contact PI
Targeting Fibroblast Growth Factor Signaling as a New Therapeutic Strategy for Meibomian Gland Dysfunction$189,756
R21 · FY2021 · EY · contact PI
Targeting Fibroblast Growth Factor Signaling as a New Therapeutic Strategy for Meibomian Gland Dysfunction$247,291
R21 · FY2020 · EY · contact PI
Programmed Cell Death in Anterior Eye Development and Peters' Anomaly$307,167
R01 · FY2018 · EY · contact PI
Programmed Cell Death in Anterior Eye Development and Peters' Anomaly$383,750
R01 · FY2017 · EY · contact PI
Programmed Cell Death in Anterior Eye Development and Peters' Anomaly$383,750
R01 · FY2016 · EY · contact PI
Programmed Cell Death in Anterior Eye Development and Peters' Anomaly$376,075
R01 · FY2015 · EY · contact PI
Programmed Cell Death in Anterior Eye Development and Peters' Anomaly$383,750
R01 · FY2014 · EY · contact PI
Ras and Phosphoinositide 3-kinase Signaling in Lens Development$75,000
R01 · FY2012 · EY · contact PI
Ras and Phosphoinositide 3-kinase Signaling in Lens Development$345,803
R01 · FY2011 · EY · contact PI
Ras and Phosphoinositide 3-kinase Signaling in Lens Development$360,212
R01 · FY2010 · EY · contact PI
Ras and Phosphoinositide 3-kinase Signaling in Lens Development$363,850
R01 · FY2009 · EY · contact PI
Ras and Phosphoinositide 3-kinase Signaling in Lens Development$346,525
R01 · FY2008 · EY · contact PI
Ras & PI 3-Kinase Signaling in Lens Development$37,375
R01 · FY2006 · EY · contact PI
Ras &PI 3-Kinase Signaling in Lens Development$253,750
R01 · FY2004 · EY
Ras &PI 3-Kinase Signaling in Lens Development$253,750
R01 · FY2003 · EY
Ras &PI 3-Kinase Signaling in Lens Development$253,750
R01 · FY2002 · EY
STUDYING MOLECULAR MECHANISMS OF EYE DEVELOPMENT USING TRANSGENIC MICE$0
P41 · FY2002 · RR
STUDYING MOLECULAR MECHANISMS OF EYE DEVELOPMENT USING TRANSGENIC MICE$0
P41 · FY2002 · RR
Ras &PI 3-Kinase Signaling in Lens Development$328,750
R01 · FY2001 · EY
STUDYING MOLECULAR MECHANISMS OF EYE DEVELOPMENT USING TRANSGENIC MICE$0
P41 · FY2001 · RR